Economics and risks of FDA’s Quality management maturity rating programme
European Pharmaceutical Review
SEPTEMBER 29, 2022
Some drug products are susceptible to active pharmaceutical ingredient (API) shortages for a variety of reasons and bifurcation in the market for finished dosage form product between brand and generic drugs, for example, likewise can affect the degree of competition and product diversification in a market.
97 
Let's personalize your content